In all stages of cancer treatment, a variety of biomedical imaging techniques are used. Imaging is an important aspect of cancer treatment procedures because it can provide morphological, structural, metabolic, and functional data. Despite breakthroughs in many areas of diagnostic radiology, human cancer detection and imaging remain a concern. Biomedical imaging is becoming increasingly relevant in all stages of cancer management. Clinical decision-making is assisted by integration with other diagnostic technologies such as in vitro tissue and fluid analyses. Early diagnosis of cancer using imaging-based screening is likely the most important factor in lowering mortality rates for some cancers. Prediction screening, biopsy advice for detection, staging, prognosis, therapy planning, therapy guidance, therapy response, recurrence, and palliation are some of the options included under biomedical imaging.
Title : A novel mRNA genomic technology for precision medicine, early cancer diagnosis, prognosis, treatment follow-up and cancer gene therapy
Rajvir Dahiya, University of California San Francisco, United States
Title : The future of pharmacogenetic polymorphism, pharmacogenomics and pharmamicrobiome in cancer treatment
Bene Ekine-Afolabi, University of East London, United Kingdom
Title : Biosensor-based detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Hospital care for cancer patients - safety, quality of care, education and respect for patient’s rights
Mariola Wioletta Borowska, Maria Sklodowska-Curie National Research Institute of Oncology, Poland
Title : Importin7 induces M2 macrophage and promotes the progress of colorectal cancer by regulating the nucleus translocation of GRP78
Changjiang Yang, Peking University People's Hospital, China
Title : Cancer-associated fibroblasts derived soluble CADM1 predicts response to neoadjuvant chemoimmunotherapy in lung cancer
Jian Li, Shanghai Jiaotong University, China